Store out of reach of children.* Patient Satisfaction Guarantee If youre deemed ineligible for therapy or medications after consultation with a Nexa Vitality provider, you will receive a full refund

Benefits AOD-9604 is believed to help with: Mechanistically designed to support fat breakdown and reduce new fat formation while having minimal direct impact on blood sugar and IGF1. May offer modest additional help with fat metabolism when combined with calorie control and exercise, particularly in higheradiposity individuals. Typically administered as a daily subcutaneous injection in low doses, integrated into a broader metabolic and lifestyle protocol. Longterm clinical safety data show generally good tolerability in studied populations, but regulators have highlighted unresolved immunogenicity and impurity concerns, so usage must remain cautious and fully consented. Positioned as an optional, supportive layernot a standalone weight-loss solutionwith emphasis on lab monitoring, habit coaching, and realistic expectations.

The Lipotropic ingredients in Lipo B-Complex tablets are manufactured in an FDA-registered facility, cGMP certified, and each batch is 3rd party tested for quality COMPREHENSIVE B-VITAMIN FORMULA: Contains all essential B-vitamins including thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin, folic acid, and vitamin B12 to support energy production, amino acid metabolism, and cell division LIPOTROPIC SUPPORT: Assists with the breakdown of fats and the production of cholesterol and certain hormones, while supporting proper mobilization of adipose tissue and increased energy throughout the day ENHANCED WITH VITAMIN C AND D3: Each tablet contains 500 mg of vitamin C to boost immune system function and fight fatigue and stress, plus vitamin D3 for additional wellness support
Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation
These are rare
Studying triple-receptor incretin effects retatrutide